{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:11:48Z","timestamp":1783901508576,"version":"3.55.0"},"reference-count":28,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    The aim of the study was to compare the results of two human papillomavirus (HPV) diagnostic techniques: human papillomavirus deoxyribonucleic acid (HPV DNA) testing and human papillomavirus E6\/E7 messenger ribonucleic acid (HPV E6\/E7 mRNA) testing in women with squamous cell abnormalities of the uterine cervix.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Material and Methods:<\/jats:bold>\n                    Comparative prospective study, conducted in the period from January 2016 to June 2017 of 128 sexually active women, age groups of 20 to 59 years (40.50 \u00b1 10.85) with squamous cell abnormalities on the cervical cytology. All patients were subject to: HPV DNA testing, HPV E6\/E7 mRNA testing and colposcopic cervical biopsy with endocervical curettage for histopathologycal analysis. HPV DNA testing was done using multiplex polymerase chain reaction (PCR) and reverse hybridization methods. HPV E6\/E7 mRNA testing was done using real-time PCR method.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Data analysis showed an association between the results of HPV DNA testing and HPV E6\/E7 mRNA testing (p\u02c20.0001). The concordance between the results of both tests was moderate (55.47%). The results show that HPV E6\/E7 mRNA testing had a higer specificity 88.89% and positive predictive value (PPV) 93.59% for HSIL + invasive squamous cell carcinoma compared to HPV DNA testing that had specificity of 55.56% and PPV 84.61%, respectively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The results of our study suggested that HPV E6\/E7 mRNA testing is more specific and has a higher positive predictive value than HPV DNA testing and that viral oncoproteins E6 and E7 are superior biomarkers for the detection of high-risk HPV-associated squamous intraepithelial lesions of the uterine cervix.\n                  <\/jats:p>","DOI":"10.2478\/prilozi-2019-0003","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:31:11Z","timestamp":1559367071000},"page":"51-58","source":"Crossref","is-referenced-by-count":13,"title":["Comparison Between HPV DNA Testing and HPV E6\/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix"],"prefix":"10.2478","volume":"40","author":[{"given":"Drage","family":"Dabeski","sequence":"first","affiliation":[{"name":"University Clinic of Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirija","family":"Duvlis","sequence":"additional","affiliation":[{"name":"Institute of Public Health of Republic of Macedonia , University \u201cSs. Cyril and Methodius\u201d , Medical Faculty , Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neli","family":"Basheska","sequence":"additional","affiliation":[{"name":"University Clinic of Radiotherapy and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Antovska","sequence":"additional","affiliation":[{"name":"University Clinic of Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Stojovski","sequence":"additional","affiliation":[{"name":"University Clinic of Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milka","family":"Trajanova","sequence":"additional","affiliation":[{"name":"University Clinic of Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Dimitrov","sequence":"additional","affiliation":[{"name":"University Clinic of Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Dabeski","sequence":"additional","affiliation":[{"name":"University Clinic of Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadica","family":"Gureva-Gjorgievska","sequence":"additional","affiliation":[{"name":"University Clinic of Gynecology and Obstetrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"2026071214541204079_j_prilozi-2019-0003_ref_001_w2aab3b7b3b1b6b1ab1ab1Aa","unstructured":"1. Scott M. The pathology of cervical cancer. In: Ayhan A, Reed N, Gulterin M, Dursun P, editors. Textbook of Gynaecological Oncology. 3rd ed. Ankara, Turkey: Gunes Publishing; 2016. pp. 376-380."},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_002_w2aab3b7b3b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. American College of Obstetricians and Gynaecologists. ACOG Practice Bulletin No99: Management of abnormal cervical cytology and histology. Obstet Gynecol 2008; 112(6); 1419-1444. Reaffirmed 2010.10.1097\/AOG.0b013e318192497c19037054","DOI":"10.1097\/AOG.0b013e318192497c"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_003_w2aab3b7b3b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. Martin CM, O\u2019Leary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. In: Arul Kumaran S, editor. Best Practice & Research: Clinical Obstetrics & Gynaecology. 25th ed. Philadelphia, USA: Elsevier; 2011. pp. 605-615.10.1016\/j.bpobgyn.2011.04.00521636328","DOI":"10.1016\/j.bpobgyn.2011.04.005"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_004_w2aab3b7b3b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. Abreu ALP, Souza RP, Gimenes F, et al. A review of methods for detect human papillomavirus infection. Virology Journal 2012; 9:262.10.1186\/1743-422X-9-262350785223131123","DOI":"10.1186\/1743-422X-9-262"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_005_w2aab3b7b3b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. 2008; 26:29-41.10.1016\/j.vaccine.2008.06.019","DOI":"10.1016\/j.vaccine.2008.06.019"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_006_w2aab3b7b3b1b6b1ab1ab6Aa","unstructured":"6. Rosenblatt S, Wroclawski ER, Lucon AM, Pereyra EAG, editors. HPV in Clinical Practice. Sao Paulo: Atheneu; 2005."},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_007_w2aab3b7b3b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. Hwang SJ, Shroyer KR. Biomarkers of Cervical Dysplasia and Carcinoma. Journal of Oncology 2012; 2012:9.10.1155\/2012\/507286320568722131995","DOI":"10.1155\/2012\/507286"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_008_w2aab3b7b3b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6\/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol 2011; 120(1):89-93.10.1016\/j.ygyno.2010.09.01320950847","DOI":"10.1016\/j.ygyno.2010.09.013"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_009_w2aab3b7b3b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. Sorbye SW, Arbyn M, Fismen S, et al. HPV E6\/ E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy. PLoS ONE 2011; 6(10):e26022.10.1371\/journal.pone.0026022318858221998748","DOI":"10.1371\/journal.pone.0026022"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_010_w2aab3b7b3b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. Kraus I, Molden T, Holm R, et al. Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33 and 45 in the Majority of Cervical Carcinomas. J Clin Microbiol 2006; 44:1310\u20131317.10.1128\/JCM.44.4.1310-1317.2006144867416597856","DOI":"10.1128\/JCM.44.4.1310-1317.2006"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_011_w2aab3b7b3b1b6b1ab1ac11Aa","unstructured":"11. Zerat L. La nouvelle terminologie de Bethesda: quellschangements? Rev Prat Gynecol Obstet. Numero Special 2002; 3-10."},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_012_w2aab3b7b3b1b6b1ab1ac12Aa","doi-asserted-by":"crossref","unstructured":"12. Solomon D, Davey D, Kurman R. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-19.10.1001\/jama.287.16.211411966386","DOI":"10.1001\/jama.287.16.2114"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_013_w2aab3b7b3b1b6b1ab1ac13Aa","unstructured":"13. Kurman RJ, Carcangin ML, Herrington CS, Young RH, editors. World Health Organization Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon, France: IARC Press; 2014."},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_014_w2aab3b7b3b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. Castle PE, Dockter J, Giachetti G, et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer. AACR 2007; 13:2599-2605.10.1158\/1078-0432.CCR-06-288117473189","DOI":"10.1158\/1078-0432.CCR-06-2881"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_015_w2aab3b7b3b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. Vieira L, Almeida A. The cytology and DNA detection by the Papillo Check test in the diagnosis of human papillomavirus infection. Eur J Microbiol Immunol 2013; 3(1):61-7.10.1556\/EuJMI.3.2013.1.9383207924265920","DOI":"10.1556\/EuJMI.3.2013.1.9"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_016_w2aab3b7b3b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. Mazarico E, Gonzalez-Bosquet E. Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology. Gynecol Oncol 2012; 125(1):181-5.10.1016\/j.ygyno.2011.12.45022226808","DOI":"10.1016\/j.ygyno.2011.12.450"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_017_w2aab3b7b3b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. Pista A, de Oliveira CF, Lopes C, et al; CLEOPATRE Portugal Study Group. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2\/3 and cervical cancer in Portugal: a CLEOPATRE II Study. Int J Gynecol Cancer 2013; 23(3):500-6.10.1097\/IGC.0b013e318280f26e23392401","DOI":"10.1097\/IGC.0b013e318280f26e"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_018_w2aab3b7b3b1b6b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. Bzhalava D, Eklund C, Dillner J. International standardization and classification of human papillomavirus types. Virology. 2015; 476:341-4.10.1016\/j.virol.2014.12.02825577151","DOI":"10.1016\/j.virol.2014.12.028"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_019_w2aab3b7b3b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. Fontecha N, Basaras M, Hernaez S, et al. Assessment of human papillomavirus E6\/E7 oncogene expression as cervical disease biomarker. BMC Cancer 2016; 16:852.10.1186\/s12885-016-2885-x509785027816058","DOI":"10.1186\/s12885-016-2885-x"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_020_w2aab3b7b3b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. Oliveira A, Verdasca N, Pista A. Use of the Nucli SENS Easy Q HPV assay in the management of cervical intraepithelial neoplasia. J Med Virol 2013; 85(7):1235-1241.10.1002\/jmv.2359023918542","DOI":"10.1002\/jmv.23590"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_021_w2aab3b7b3b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. Cattani P, Siddu A, D\u00d3nghia S, et al. RNA (E6 and E7) assay versus DNA (E6 and E7) assay for risk evaluation for women infected with human papillomavirus. J Clin Microbiol 2009; 2136-2141.10.1128\/JCM.01733-08270847519403762","DOI":"10.1128\/JCM.01733-08"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_022_w2aab3b7b3b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. Tuney I, Altay A, Ergunay K, et al. HPV types and E6\/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey. Turk J Med Sci 2017; 1508-155.10.3906\/sag-1508-15528263489","DOI":"10.3906\/sag-1508-155"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_023_w2aab3b7b3b1b6b1ab1ac23Aa","unstructured":"23. Doganov A, Kostova P, Boyanova M, et al. Application of the RNA-based HPV test in the diagnostics of cervical epithelial changes. Akush Ginekol 2012; 51(3):22-4."},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_024_w2aab3b7b3b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. Trope A, Sjoborg K, Eskild A, et al. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 2009; 47(8):2458-2464.10.1128\/JCM.01863-08272563919535524","DOI":"10.1128\/JCM.01863-08"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_025_w2aab3b7b3b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. Spathis A, Kottaridi C, Chranioti A, et al. mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics. PLoS One 2012; 7(11):e49205.10.1371\/journal.pone.0049205349955523166611","DOI":"10.1371\/journal.pone.0049205"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_026_w2aab3b7b3b1b6b1ab1ac26Aa","doi-asserted-by":"crossref","unstructured":"26. Salimovic-Besic I, Tomic-Cica A, Smailjic A, et al. Comparison of the detection of HPV-16, 18, 31, 33 and 45 by type-specific DNA- and E6\/ E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears. J virol Methods 2013; 194(1-2):222-228.10.1016\/j.jviromet.2013.08.03624036071","DOI":"10.1016\/j.jviromet.2013.08.036"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_027_w2aab3b7b3b1b6b1ab1ac27Aa","doi-asserted-by":"crossref","unstructured":"27. Duvlis S, Popovska-Jankovic K, Sarafimovska- Arsova Z, et al. HPV E6\/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women. J Med Virol 2015; 87(9):1578-1586.10.1002\/jmv.2419925880030","DOI":"10.1002\/jmv.24199"},{"key":"2026071214541204079_j_prilozi-2019-0003_ref_028_w2aab3b7b3b1b6b1ab1ac28Aa","doi-asserted-by":"crossref","unstructured":"28. Munkhdelger J, Choi Y, Lee D, et al. Comparison of the performance of the Nucli SENS Easy Q HPV E6\/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix. Diagnos Microbiol Inf Dis 2014; 422-427.10.1016\/j.diagmicrobio.2014.04.00424856365","DOI":"10.1016\/j.diagmicrobio.2014.04.004"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/prilozi\/40\/1\/article-p51.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2019-0003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:24Z","timestamp":1783900824000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2019-0003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,5,31]]},"published-print":{"date-parts":[[2019,5,1]]}},"alternative-id":["10.2478\/prilozi-2019-0003"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2019-0003","relation":{},"ISSN":["1857-8985","1857-9345"],"issn-type":[{"value":"1857-8985","type":"electronic"},{"value":"1857-9345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}